Brian Wachter is currently the Director of Global Regulatory Affairs CMC at Eli Lilly and Company, a position held since 2024. They have previously served as the Director of CMC Regulatory Affairs at Aurinia Pharmaceuticals Inc. from 2020 to 2024 and as an Associate Director at Boehringer Ingelheim from 2018 to 2020. Brian's foundational experience in regulatory affairs includes roles at leading pharmaceutical companies such as Boehringer Ingelheim Animal Health, Mallinckrodt Pharmaceuticals, and King Pharmaceuticals, where they held positions from Senior Manager to Regulatory Affairs Specialist. They earned a B.S. in Chemistry and an MBA in Business from Southern Illinois University Edwardsville and Fontbonne University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices